Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
Cell Therapeutics (CTIC) Meets with FDA, Clears Pathway for Pixantrone NDA Resubmission
June 14, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6578276 for the full story.
Read More
from
StreetInsider.com News Articles
Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval
June 14, 2011
- Received guidance on information needed for resubmission and approaches to address items in complete response letter
Read More
from
PR Newswire
More News
Read More
Cell Therapeutics on Preliminary List of Additions to Russell 3000® Index and Russell Global Index
June 13, 2011
from
PR Newswire
Cell Therapeutics Provided Interim Results From The Phase II OPAL Study Of Tosedostat (CTIC)
June 06, 2011
from
Comtex SmarTrend® News Briefs
Cell Therapeutics (CTIC) Releases Posivite Results in Treatment with OPAXIO,Temozolomide, and Radiotherapy
June 06, 2011
from
StreetInsider.com News Articles
Treatment with OPAXIO® (Paclitaxel Poliglumex),Temozolomide and Radiotherapy Results in Encouraging Progression Free Survival in Patients With High Grade Malignant Brain Tumors
June 06, 2011
from
PR Newswire
New Interim Phase II Clinical Data from the OPAL Study Demonstrate Encouraging Single Agent Response Rates for Tosedostat in Elderly Patients with Relapsed Refractory AML
June 06, 2011
from
PR Newswire
Cell Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Rule
June 01, 2011
from
PR Newswire
CTI Provides Update on New Product Acquisition Strategy and Upcoming ASCO Events
May 26, 2011
from
PR Newswire
Cell Therapeutics (CTIC) to Meet with FDA Over Pixantrone NDA Submission
May 20, 2011
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here